HopeMed advances its androgenetic alopecia treatment to Phase II trials
Hope Medicine has kickstarted recruitment for a Phase II trial assessing its monoclonal antibody HMI-115 for androgenetic alopecia, after the…
Hope Medicine has kickstarted recruitment for a Phase II trial assessing its monoclonal antibody HMI-115 for androgenetic alopecia, after the…
Genexine has reported that the Phase III study of eftansomatropin alfa (GX-H9) for the treatment of children with growth hormone…
US-based pharmaceutical company Xeris Biopharma has dosed the first participant in a Phase II clinical trial of subcutaneous (SC) XP-8121…
Extend Biosciences has reported positive results from its first-in-human Phase I clinical trial of EXT608 for the treatment of hypoparathyroidism,…
This week on Pipeline Moves, we start with the completion of Novartis’s Phase II trial in ulcerative colitis. We also…
Telemedicine remains the leading decentralisation approach in clinical trials in Q2 of this year. The continued rise of telemedicine as…
In this edition of Pipeline Moves, the Clinical Trials Arena team kicks off with an analysis of the termination of…
OPKO Health and Pfizer have reported positive results from the Phase III clinical trial of somatrogon compared to Genotropin (somatropin)…